BTCY — Biotricity Cashflow Statement
0.000.00%
Last trade - 00:00- $10.47m
- $36.50m
- $12.06m
- 48
- 61
- 62
- 58
Annual cashflow statement for Biotricity, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -11.1 | -15.5 | -29.1 | -18.7 | -14.1 |
| Depreciation | |||||
| Non-Cash Items | 3.49 | 5.04 | 14.1 | 2.72 | 3.71 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.287 | -0.628 | -0.118 | 2.38 | 3.68 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -7.86 | -11.1 | -15.2 | -13.5 | -6.69 |
| Capital Expenditures | — | — | -0.03 | 0 | — |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | — | — | -0.03 | 0 | — |
| Financing Cash Flow Items | 0 | — | — | — | — |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 8.88 | 12.2 | 25.2 | 2 | 6.74 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.886 | 1.25 | 9.87 | -11.5 | 0.216 |